Stocks News

LAST PRICE
275.1300
TODAY'S CHANGE (%)
Trending Up4.6800 (1.7304%)

Bid / Lots
235.9900/ 12
Ask / Lots
274.7400/ 1
Open / Previous Close
270.4400 / 270.4500
Day Range
Low 268.6500
High 275.5300
52 Week Range
Low 205.9300
High 279.9800
Volume
1,143,147
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 21, 2024
- DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones
  12:23PM ET on Tuesday May 21, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 21, 2024 12:23 ET (16:23 GMT)
May 16, 2024
- United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires
  4:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:41 PM EDT, 05/16/2024 (MT Newswires) -- Christopher Causey, Director, on May 15, 2024, sold 2,000 shares in United Therapeutics (UTHR) for $545,800. Following the Form 4 filing with the SEC, Causey has control over a total of 4,185 shares of the ...
May 14, 2024
- United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:39 PM EDT, 05/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 10, 2024
- United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires
  4:41PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:41 PM EDT, 05/10/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 08, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,898,393. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 8, 2024
- United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: UTHR
  05:15 PM EDT, 05/08/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 07, 2024, sold 3,600 shares in United Therapeutics (UTHR) for $949,737. Following the Form 4 filing with the SEC, Rothblatt has control over a total ...

Today
- Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing, from 19 hours ago by MT Newswires
  19 hours ago by MT Newswires
  Companies Mentioned: NBIX
- BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 19 hours ago by MT Newswires
  19 hours ago by MT Newswires
  Companies Mentioned: BMRN
May 29, 2024
- Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 29, 2024 by MT Newswires
  4:28PM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: MEDP
- TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target, from 7:45AM ET on Wednesday May 29, 2024 by MT Newswires
  7:45AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 28, 2024
- Neurocrine Biosciences Says CEO Kevin Gorman Retiring, from 5:09PM ET on Tuesday May 28, 2024 by MT Newswires
  5:09PM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: NBIX
- UBS Raises Price Target on Neurocrine Biosciences to $193 From $174, Maintains Buy Rating, from 9:20AM ET on Tuesday May 28, 2024 by MT Newswires
  9:20AM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: NBIX
- Mizuho Starts Medpace Holdings With Buy Rating, $435 Price Target, from 8:01AM ET on Tuesday May 28, 2024 by MT Newswires
  8:01AM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 24, 2024
- Sector Update: Health Care Stocks Advance Pre-Bell Friday, from 9:16AM ET on Friday May 24, 2024 by MT Newswires
  9:16AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: EXAS, IBB, XLV, VSTM, GH
- Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test, from 8:31AM ET on Friday May 24, 2024 by MT Newswires
  8:31AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: EXAS
May 22, 2024
- Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing, from 4:29PM ET on Wednesday May 22, 2024 by MT Newswires
  4:29PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: MEDP

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

May 21, 2024

DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones

May 16, 2024

United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires

May 10, 2024

United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires

May 8, 2024

United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires

Peers Headlines

Today

Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing, from 19 hours ago by MT Newswires

BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 19 hours ago by MT Newswires

May 29, 2024

Medpace Holdings Insider Sold Shares Worth $3,828,058, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 29, 2024 by MT Newswires

TD Cowen Starts Medpace Holdings With Buy Rating, $452 Price Target, from 7:45AM ET on Wednesday May 29, 2024 by MT Newswires

May 28, 2024

Neurocrine Biosciences Says CEO Kevin Gorman Retiring, from 5:09PM ET on Tuesday May 28, 2024 by MT Newswires

UBS Raises Price Target on Neurocrine Biosciences to $193 From $174, Maintains Buy Rating, from 9:20AM ET on Tuesday May 28, 2024 by MT Newswires

Mizuho Starts Medpace Holdings With Buy Rating, $435 Price Target, from 8:01AM ET on Tuesday May 28, 2024 by MT Newswires

May 24, 2024

Sector Update: Health Care Stocks Advance Pre-Bell Friday, from 9:16AM ET on Friday May 24, 2024 by MT Newswires

Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test, from 8:31AM ET on Friday May 24, 2024 by MT Newswires

May 22, 2024

Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing, from 4:29PM ET on Wednesday May 22, 2024 by MT Newswires